Bharat Immuno (Results) revenue elevated to 26.5 crores up 7.3% in Sep 2022 quarter, compared with 24.7 crores in Sep 2021. Its Net loss is -3.1 crores up 67% in Sep 2022 quarter, compared with -9.4 crores in last year same quarter.
“Bharat Immuno, Stock market Data of India from Nifty – NSE, Sensex – BSE. * Data is Only for educational purpose, not for trading. Please verify Data with latest sources.
* Consult your financial advisor before trading or investing in any stock.”
“Bharat Immuno, Stock market Data of India from Nifty – NSE, Sensex – BSE. * Data is Only for educational purpose, not for trading. Please verify Data with latest sources.
* Consult your financial advisor before trading or investing in any stock.”
“Bharat Immuno, Stock market Data of India from Nifty – NSE, Sensex – BSE. * Data is Only for educational purpose, not for trading. Please verify Data with latest sources.
* Consult your financial advisor before trading or investing in any stock.”